RIO DE JANEIRO, BRAZIL - The US will begin human trials of gene therapy that is considered a "potential cure" for HIV next month. The FDA - Food and Drug Administration - on August 11th authorized AGT, American Gene Technologies, to initiate phase 1 human trials.
The news was disclosed by the American scientific journal Outsourcing Pharma.
"This is important news, that we have FDA approval to initiate phase I and conduct our first human trials... We are very excited... This brings us closer to our goal of changing lives through genetic medicine," said David Pauza, Director of Science at AGT.
Genetic . . .